Clinical Trial Details

Trial ID: L0872
Source ID: IRCT2015062922977N1
Associated Drug: Cinnamon
Title: Evaluating Cinnamon Effects on Clinical, Serologic and Sonographic Characteristics of Non-Alcoholic Fatty Liver Disease patients
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Non-Alcoholic Fatty Liver Disease. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
Interventions: Intervention 1: In the treatment group (Cinnamon group) all patients will receive 750 mg cinnamon capsules twice daily for 12 weeks starting after initial assessments. Intervention 2: In the control group, all patients will receive 750 mg placebo capsule
Outcome Measures: Fatty liver score in ultrasound. Timepoint: Before intervention and after three months of intervention. Method of measurement: Ultrasound evaluations of abdomen.;Fasting Blood Sugar (FBS). Timepoint: Before intervention and after three months of intervention. Method of measurement: colorimetric enzymatic method.;HbA1C. Timepoint: Before intervention and after three months of intervention. Method of measurement: measured by affinity chromatographic method.;Triglycerides, Total Cholesterol, Low-density Lipoprotein (LDL), and High-density Lipoprotein (HDL). Timepoint: Before intervention and after three months of intervention. Method of measurement: Colorimetric Enzymatic Method.;Serum ALT and AST Concentration. Timepoint: Before intervention and after three months of intervention. Method of measurement: UV Test.;Weight (kg). Timepoint: Before intervention and after three months of intervention. Method of measurement: Digital scale with minimal clothing and no shoes.;Body Mass Index (BMI). Timepoint: Before intervention and after three months of intervention. Method of measurement: Weight (kilograms) divided by the square of height (meters).;Waist Circumference. Timepoint: Before intervention and after three months of intervention. Method of measurement: non-stretchable tape without any pressure (cm).nan
Sponsor/Collaborators: Deputy of Research Development Ahvaz Jundishapur University of Medical Sciences
Gender: All
Age: 18 years65 years
Phases: Phase 1/Phase 2
Enrollment: 120
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
Start Date: 20/07/2015
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/19715